UPC CFI 903/2026

Mar 12, 2026·EP3345604 +1 more · NALMEFENE FOR REDUCTION OF ALCOHOL CONSUMPTION IN SPECIFIC TARGET POPULATIONS

Case details: Status
Case Closed (Withdrawn)
Action
Provisional measures
Category
Provisional measures
Parties: Claimants
H. Lundbeck A/SOperating co.
Representatives
Benoît Strowel-Hoyng Rokh Monegier
Respondents
BIOGARANOperating co.
Representatives
Marianne Gabriel-Casalonga
Jean-Baptiste Lecoeur-Casalonga
Patents: EP3345604
EP4223296Unitary patent
Division: Paris LD
Judges: Camille Lignières
Carine Gillet
Anna-Lena Klein
Eric Enderlin
Technology: Chemistry
Pharmaceuticals
Language: English
EPO Opposition: Alfred E. Tiefenbacher (GmbH & Co. KG)Admissible2024-03-01
BIOGARANAdmissible2024-03-06
Alfred E. Tiefenbacher (GmbH & Co. KG)Admissible2025-10-27
BIOGARANAdmissible2025-10-29

How this compares

The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.

	Preliminary injunction granted	Median days to first decision
All UPC	54% (38/70)	124
Paris LD	Locked	Locked
Judge Camille Lignières	Locked	Locked
Judge Carine Gillet	Locked	Locked
Judge Anna-Lena Klein	Locked	Locked
Judge Eric Enderlin	Locked	Locked

At the UPC: H. Lundbeck A/S (2 cases)·BIOGARAN (2 cases)

Related cases

More cases: Paris LD·2026

Decisions

—
provisional measures
Summary: 1.The withdrawal of the provisional measures action against Defendant is permitted, pursuant to R. 265.2 RoP, 2. The present proceedings are declared without object and closed,

Documents